The Caregiver Confidence in Sign/Symptom Management (CCSM) scale is a caregiver-reported measure that assesses caregiver confidence in their ability to manage care recipient signs and symptoms. It consists of 25 items, each rated on a 5-point Likert scale ranging from 1 (not at all confident/true) to 5 (extremely confident/true). Total scores are calculated by summing responses across all items, with possible scores ranging from 25 to 125. Higher scores indicate greater caregiver confidence in managing signs and symptoms, whereas lower scores indicate lower confidence.

This control condition will act as the active comparator to the experimental condition. The same assistive technology, the MapHabit System (MHS), will be given to a separate group of participants. The difference here will be that the system will be a version that does not include the caregiver training program.

Total of all reporting groups

Data is organized to report sex of the caregiver and respective care recipient separately in a given dyad.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

Data is organized to report race of the caregiver and respective care recipient separately in a given dyad.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

Data is organized to report ethnicity of the caregiver and respective care recipient separately in a given dyad.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The instrument consists of 22 items that evaluate the caregiver's perceived emotional, social, and physical burden. Each item is rated on a 5-point Likert scale ranging from 0 (Never) to 4 (Nearly Always). Total scores range from 0 to 88, with higher scores indicating greater caregiver burden. The total score is calculated by summing responses across all items.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The ADCS-ADL is a validated caregiver-reported measure of functional ability in individuals with dementia. The inventory assesses performance in basic and instrumental activities of daily living through a structured caregiver interview. Higher scores indicate greater functional independence and lower scores indicating greater impairment. The scale consists of 23 items administered via a structured interview with a caregiver or informant. Total scores are calculated by summing item responses, with possible scores ranging from 0 to 78.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The Rapid Caregiver Well-being Scale (R-CWBS) consists of 6 items. Each item is rated on a 5-point Likert scale reflecting the caregiver's experiences and perceptions of well-being, with higher scores indicating greater caregiver well-being. Total scores are calculated by summing responses across all items, with higher scores reflecting better overall well-being and lower scores indicating greater caregiver strain or distress. Minimum score: 6 (all items scored 1) Maximum score: 30 (all items scored 5).

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The Caregiver Confidence in Sign/Symptom Management (CCSM) scale is a caregiver-reported measure that assesses caregiver confidence in their ability to manage care recipient signs and symptoms. It consists of 25 items, each rated on a 5-point Likert scale ranging from 1 (not at all confident/true) to 5 (extremely confident/true). Total scores are calculated by summing responses across all items, with possible scores ranging from 25 to 125. Higher scores indicate greater caregiver confidence in managing signs and symptoms, whereas lower scores indicate lower confidence.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

This control condition will act as the active comparator to the experimental condition. The same assistive technology, the MapHabit System, will be given to a separate group of participants. The difference here will be that the software will be a version that does not include the caregiver training program.

The ADCS-ADL is a validated caregiver-reported measure of functional ability in individuals with dementia. The inventory assesses performance in basic and instrumental activities of daily living through a structured caregiver interview. Higher scores indicate greater functional independence and lower scores indicating greater impairment. The scale consists of 23 items administered via a structured interview with a caregiver or informant. Total scores are calculated by summing item responses, with possible scores ranging from 0 to 78.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

18-item quality-of-life questionnaire (QoL-18) evaluated a range of participants' behaviors, including mood, engagement, and memory at the end of the study compared to baseline. The instrument is scored on a Likert Scale, ranging from 1-5. Final score is calculated as sum of all question scores. Minimum score of 18 and maximum score of 90. A higher number indicates better outcome compared to baseline.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The Rapid Caregiver Well-being Scale (R-CWBS) consists of 6 items. Each item is rated on a 5-point Likert scale reflecting the caregiver's experiences and perceptions of well-being, with higher scores indicating greater caregiver well-being. Total scores are calculated by summing responses across all items, with higher scores reflecting better overall well-being and lower scores indicating greater caregiver strain or distress. Minimum score: 6 (all items scored 1) Maximum score: 30 (all items scored 5).

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

The Caregiver Confidence in Sign/Symptom Management (CCSM) scale is a caregiver-reported measure that assesses caregiver confidence in their ability to manage care recipient signs and symptoms. It consists of 25 items, each rated on a 5-point Likert scale ranging from 1 (not at all confident/true) to 5 (extremely confident/true). Total scores are calculated by summing responses across all items, with possible scores ranging from 25 to 125. Higher scores indicate greater caregiver confidence in managing signs and symptoms, whereas lower scores indicate lower confidence.

For analysis of baseline and final outcomes, number of participants analyzed reflect participants who fully completed the study in order to adhere to the study's primary objective in assessing pre-post differences in outcomes. Differences in numbers between groups are explained by participant withdrawal, lost to follow ups, etc.

This condition will involve the implementation of an assistive technology software, the MapHabit System (MHS), with an added Caregiver Training Program (CTP) into the caregiver's daily care for their individual with mild to moderate stages of Alzheimer's disease and related dementias. The MapHabit System (MHS) is a commercially available visual mapping software application that utilizes visual, audio, and text media to create step-by-step visual guides to assist individuals and their caregivers in structuring and accomplishing activities of daily living (ADLs). The application will be made available to caregivers through compatible tablets. CTP will integrate a personalized caregiver education service into MHS, in which participants will engage in training sessions and related educational materials with dementia support coaches.

The care recipient of a given dyad only.

This control condition will act as the active comparator to the experimental condition. The same assistive technology, the MapHabit System (MHS), will be given to a separate group of participants. The difference here will be that the system will be a version that does not include the caregiver training program.

Primary caregiver of a given dyad only.

This control condition will act as the active comparator to the experimental condition. The same assistive technology, the MapHabit System (MHS), will be given to a separate group of participants. The difference here will be that the system will be a version that does not include the caregiver training program.

The care recipient of a given dyad only.